Legal status · United States
Is Icotrokinra legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Icotrokinra is not an approved medicine in the United States; its classification is "Prescription only; FDA approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Icotrokinra in the United States at a glance
| Classification | Prescription only; FDA approved |
|---|---|
| FDA approval status | FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only. |
| Human studies cited | 2 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Icotrokinra profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Icotrokinra is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Icotrokinra is
A 13 amino acid peptide taken as a tablet that blocks the IL-23 receptor. The first oral drug to hit that pathway, in a class that was injection only.
Interleukin-23 drives plaque psoriasis, and the drugs that block it are among the most effective treatments there are. All of them were injected antibodies.
Mechanism: Binds the IL-23 receptor with picomolar affinity and blocks IL-23 signalling. Conventional IL-23 drugs are antibodies that bind the cytokine itself; this binds the receptor, and its small peptide size is what makes oral dosing possible.
Regulatory history: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Icotrokinra at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Icotrokinra in other countries
United Kingdom
Not approvedPrescription only; check current MHRA status
Is Icotrokinra legal in the United Kingdom?Australia
Not approvedPrescription only; check current TGA status
Is Icotrokinra legal in Australia?Canada
Not approvedPrescription only; check current Health Canada status
Is Icotrokinra legal in Canada?Frequently asked questions
Is Icotrokinra legal in the United States?
No. Icotrokinra is not an approved medicine in the United States; its classification is "Prescription only; FDA approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy Icotrokinra in the United States?
No approved product exists to buy. In the United States Icotrokinra is classified as "Prescription only; FDA approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Icotrokinra FDA approved?
No. FDA status: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.. Current US classification: "Prescription only; FDA approved". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Icotrokinra live on its compound profile.
Icotrokinra profileThis page is general information about the regulatory status of Icotrokinra in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.